Saturday, January 17, 2026 10:45:18 AM
Investor082,
So tell me why you expected approval by end of May in 2024. Was it because you were expecting a manufacturing Update about a GMP approved Flaskworks prototype which is what Linda was expecting to have to announce at the June 2024 ASM? Now you know why I believe manufacturing progress for sustained commercial viability is key to approval and my revenue projections. As proven by your mistaken guess on approval, you are only guessing as to when that manufacturing piece of the puzzle will be fitted into the picture. Based on the hints given at this last year’s ASM that piece should be ready before the end of June which is approximately 2 years since the failure of the previous prototype to be found fit for purpose. This is a reasonable amount of time for a new engineering firm not tied to original creator Sashi Murthy to take an existing previous prototype and make it GMP compliant which is what should have happened last time. Looking forward to that update; ). Best wishes.
So tell me why you expected approval by end of May in 2024. Was it because you were expecting a manufacturing Update about a GMP approved Flaskworks prototype which is what Linda was expecting to have to announce at the June 2024 ASM? Now you know why I believe manufacturing progress for sustained commercial viability is key to approval and my revenue projections. As proven by your mistaken guess on approval, you are only guessing as to when that manufacturing piece of the puzzle will be fitted into the picture. Based on the hints given at this last year’s ASM that piece should be ready before the end of June which is approximately 2 years since the failure of the previous prototype to be found fit for purpose. This is a reasonable amount of time for a new engineering firm not tied to original creator Sashi Murthy to take an existing previous prototype and make it GMP compliant which is what should have happened last time. Looking forward to that update; ). Best wishes.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
